Tuesday, March 10, 2009

Gardasil -- Statistics and More

This won't be a short posting because I want to cover as much as I can for anyone researching the ins and outs of Gardasil. I would personally NOT get my daughter one. HPV is an epidemic, no doubt about it. Guys have no symptoms and casual sex is a serious problem. It's time to attack the problem at the bottom line....chastity! There are many many more good reasons to be chaste than most people even think about. A woman is empowered by chastity!


Tuesday July 8, 2008

Gardasil - 18 Dead, Thousands Suffer Complications
Growing opposition and flat sales trigger Gardasil manufacturer Merck stock sell-off



By Thaddeus M. Baklinski

July 8, 2008 (LifeSiteNews.com) - The public interest group Judicial Watch recently obtained more than 8,000 reports, under the US Freedom of Information law, of adverse events in girls and young women after they were injected with the HPV vaccine Gardasil.

The reports reveal everything from massive wart outbreaks to seizures, paralysis and death.

Ten deaths have been reported since September 2007, bringing the total to 18 since the vaccine was approved for use in 2006.

In this year there have been 140 reported "serious" complications, 27 of which were categorized as "life-threatening," as well as ten spontaneous abortions and six cases of Guillain-Barré Syndrome, a very rare (1 in 100,000 in a healthy population) immune response to foreign antigens such as infectious agents or vaccines, that paralyzes the afflicted person.

"Given all the questions about Gardasil, the best public health policy would be to reevaluate its safety and to prohibit its distribution to minors. In the least, governments should rethink any efforts to mandate or promote this vaccine for children," stated Judicial Watch President Tom Fitton.

Gwen Landolt, national vice-president of REAL Women of Canada commented on the lack of proper testing before Gardasil was pushed through the approval process and the consequences of its widespread use.

"The long-term consequences of Gardasil are not known. The manufacturer admits this and agrees it does not know its effect on young girls' cancer risk, on their immunity system, on their reproductive system, or its genetic effects. In due course, we will know this, possibly in twenty or thirty years from now when these young girls, the innocent subjects of the Gardasil experiment have become grown women and then report the consequences of their having taken the medication in their childhood on medical advice."

Cynthia Janak, a freelance journalist and researcher, reported to the American Life League that she found evidence in the FDA's documentation that they knew that HPV is not the actual cause of cervical cancer but that the actual cause is a "persistent HPV infection that may act as a tumor promoter in cancer induction."

Janak explains: "What we have here is proof that there is scientific evidence that has been published in the past 15 years that states that HPV infection does not bear a direct relationship to the forming of cervical cancer. It also tells us that HPV, if allowed to will be taken care of by our own body's natural processes. . ."most infections are short-lived and not associated with cervical cancer." With this being said, why do we need Gardasil when our own body is more than capable of eradicating HPV? What we need is a government policy to assist women with the cost of getting follow-up tests when persistent HPV infection is present. This would make more sense and our government would save so much money on these types of programs instead of $360 each for the Gardasil vaccination."

The Judicial Watch press release concluded that "It could well be that the vaccine may not do a thing to protect anyone from cervical cancer, regardless of the claims being made by Merck Pharmaceutical. What the vaccine is causing is death and immense suffering among those who have been vaccinated."

After CBS News ran a story about the reported side effects of Gardasil, citing the 8,000 adverse event reports and giving details of a few serious complications - seizures, chronic pain, paralysis, and death from blood clots, the Wall Street Journal reported that Merck & Co.'s shares dropped 4.8% triggering a sell-off of the company's stock and a downgrade of their rating on the New York Stock Exchange.

Read related LifeSiteNews.com coverage and articles:

Why Medical Authorities Cannot be Trusted on Gardasil HPV Vaccine By Gwen Landolt

Ontario Catholic School Board Rejects HPV Vaccine on School Premises

Controversial HPV Vaccine Causing One Death Per Month: FDA Report


Why Medical Authorities Cannot be Trusted on Gardasil HPV Vaccine



By Gwen Landolt

TORONTO, December 19, 2007 (LifeSiteNews.com) - Medical health authorities have repeatedly assured us that Gardasil, the vaccine injection given to young girls to allegedly prevent cervical cancer, is perfectly safe. For example, the National Advisory Committee on Immunization, a group of medical specialists, endorsed the vaccine last February. The Society of Gynecologic Oncologists of Canada claims the vaccine is safe, as does Dr. David Butler-Jones, Canada's Chief Public Health Officer. The Canadian Pediatric Society and the Society of Obstetricians and Gynecologists of Canada have also endorsed the vaccine.

These medical authorities, however, are puzzled and also indignant that the use of this vaccine still remains controversial, ever since it was rolled out in lightening speed after Ottawa announced a $300 million funding package for participant provinces. After all, they reason, they have approved the drug, so what is the problem? Surely their expert opinion should be sufficient to allay the public's fears about the drug?

The reason the public has good reason to distrust the judgement of these medical authorities is because of their experience with them. It is a fact that the public has heard many similar assurances about other drugs, and used them to their lasting regret. For example:

- In the 1960's, thalidomide was pronounced a safe drug for pregnant women experiencing morning sickness. It was not safe, as thousands of adults with flipper arms and legs can attest.

- In the 1960's, the birth control pill was developed and women were assured that its use had no harmful side effects. Studies now report that the pill can be the cause of a greatly increased risk of stroke, heart attack and blood clots if taken for eight years or more. (British Journal of Medicine, 16 or 17 September, 2007).

- Between 1938 and 1971, as many as 4 million U.S. women and many Canadian women took the drug, diethylstilbestrol (DES) to prevent miscarriage. Daughters of these women who were exposed to DES in utero have experienced a range of structural reproductive tract abnormalities in the uterus, cervix and vagina. The incidents of abnormality occurs in 18% of cases, but it may be as high as 33% in women exposed to DES in utero. The male offspring of women who took DES during pregnancy also have an increased incidence of genital abnormalities and a possibility of increased risk of prostrate and testicular cancer.

- Merck Frosst, the manufacturer of Gardasil, also developed a much-acclaimed painkiller called Vioxx, that was subsequently used by thousands of individuals suffering from arthritis. Unfortunately, the drug had the side effect of causing heart attacks and strokes. As a result, the medication was taken off the market in 2004 and Merck Frosst is now facing thousands of class action suits amounting to billions of dollars in claims.

- By 2001, 15 million women in the U.S. alone, as well a millions of women in Canada and abroad, were taking hormone-replacement therapy (H.R.T.). It became one of the most popular prescription drug treatments for menopause, supposedly to allow women to lead a long and healthier life. However, in July 2002, estrogen therapy was exposed as a hazard to health, rather than a benefit. It was found to constitute a potential health risk for post-menopausal women by increasing risks of heart disease, stroke, blood clots and breast cancer. The question lingers unanswered, as to how many women may have died prematurely because their physician prescribed this medication? A reasonable estimate would be tens of thousands of women. (New York Times, September 16, 2007)

- Europe's largest drug manufacturer GlaxoSmithKline developed and sold the diabetic drug Avandia, it's second best selling product last year, which was subsequently linked to a higher risk of heart attacks according to a study released in May 2007. This caused sales of the drug to drop 38%.

These are just a few examples of the here-today gone-tomorrow nature of medical wisdom. What we are advised about with confidence one year is reversed the next. One of the contributing factors to this reversal is that the kind of experimental trials necessary to determine the truth about the medication is excessively expensive and time-consuming and very often does not happen. Hence, the problem with these new drugs so enthusiastically recommended by the medical profession.

It is alarming that Gardasil's approval was based on the testing of only a few thousand patients and almost not at all (only 1200) on young girls, 9-13 years old, who are targeted for injection of the drug. (See REALity Sept/Oct. 2007, p. 5)

As its marketing plan, Merck Frosst used lobbyists with access to important public officials. In Canada, Ken Boessenkool, now with the public relations firm of Hill and Knowlton in Calgary, lobbied the federal government on Merck Frosst's behalf. Mr. Boessenkool was a former advisor to Prime Minister Stephen Harper when he was opposition leader. Jason Grier, former executive assistant to Ontario Health Minister George Smitherman, also lobbied on behalf of Merck and Ontario has now decided to administer the drug to young girls.

Even though only approximately 2-5% of women have Pap smears with cell changes due to HPV, the medication was pushed as a preventative cure for cervical cancer. However, no mention was made of the fact that the drug does not protect against other sexually transmitted diseases, such as chlamydia, herpes, hepatitis, trichomoniasis, gonorrhea, syphilis, HIV, AIDS, etc. It's all promotion; facts do not count.

The long-term consequences of Gardasil are not known. The manufacturer admits this and agrees it does not know its effect on young girls' cancer risk, on their immunity system, on their reproductive system, or its genetic effects. In due course, we will know this, possibly in twenty or thirty years from now when these young girls, the innocent subjects of the Gardasil experiment have become grown women and then report the consequences of their having taken the medication in their childhood on medical advice.

This artcicle was originally published in the Nov./Dec. edition of REAL Women of Canada's Reality magazine. Republished with permission.


Support for HPV Vaccine Gardasil Helps Planned Parenthood Says LDI President



By Peter J. Smith

WASHINGTON, D.C., October 18, 2007 (LifeSiteNews.com) – Gardasil, Merck’s questionable new vaccine against cervical cancer is expected to rake in at least a billion dollars in profits from sales, which will leave the pharmaceutical giant with more cash to donate to abortion giant Planned Parenthood.

Merck has a long history of supporting abortion and Gardasil profits could turn into a financial boost for Planned Parenthood, especially as US states and Canadian provinces begin either to encourage or require HPV vaccination for girls as young as 9.

“You’re going to increase their profits, which mean it’s going to increase the amount [for Planned Parenthood],” said Douglas Scott, President of Life Decisions International (LDI), a group that has a boycott list of organizations that give financial support to the abortion movement. Scott told LifeSiteNews.com that although PP has “more money than they can count” or approximately $480 million in the bank, “You still don’t want Planned Parenthood to get any more money to do any more damage than its already doing.”

However, Scott added that Merck’s endorsement is even more important to the abortion provider than its slice of the Gardasil profits.

“What they want is the corporate stamp of approval, the (cream of the) crop endorsement. They want to be able to tell people, ‘Merck supports us; we’re a legitimate organization,’” Scott stated. “Any sort of a connection between Planned Parenthood and any corporation only benefits Planned Parenthood on the public relations side, which is a lot more important and more devastating.”

Merck waged a heavy campaign earlier in the year advertising Gardasil as a vaccine for cervical cancer caused by the human papilloma virus (HPV) to convince states to mandate vaccination against cervical cancer. However the vaccine only prevents some, not all, of HPV forms contracted through promiscuous sexual activity. The campaign would edge out a competing HPV vaccine, Glaxo Smith Kline's Cervarix, which is incompatible with Gardasil and hits the market in January 2008.

Judicial Watch, a government watchdog organization, has uncovered least 11 deaths from Gardasil injections, from a partial release of information from the US Food and Drug Administration. In early October the US Government's Vaccine Adverse Event Reporting System (VAERS) listed at least 3,779 adverse effects of which 52 were deemed "life threatening" and 119 required hospitalization. JW has filed a lawsuit demanding full release of the information from the FDA.

See related coverage by LifeSiteNews.com:

US Death Toll Associated with HPV Vaccine Jumps to 11 with 3779 Adverse Reactions Reported

Canada's Conservative Government Distributes $300 Million to Provinces for Controversial HPV Vaccination


Controversial HPV Vaccine Causing One Death Per Month: FDA Report

140 "serious" adverse reactions, including 27 "life threatening" cases, 10 spontaneous abortions, and 6 cases of the debilitating Guillain-Barre Syndrome reported since January 2008

By Peter J. Smith

WASHINGTON, D.C., July 3, 2008 (LifeSiteNews.com) - One death per month is the average loss of life associated with the cervical cancer vaccine Gardasil according to an FDA report obtained by a government watchdog agency.

Merck, the makers of Gardasil, are poised to make profits in the billions from the vaccine, which protects against some cancer-causing forms of the sexually transmitted human papilloma virus (HPV), but the pharmaceutical giant has come under heavy criticism for fast-tracking the drug onto the market without adequate testing in order to beat out its rivals.

Judicial Watch, a public interest group that campaigns against government corruption, uncovered documents through the Freedom of Information Act that show the US Food and Drug Administration (FDA) received reports of 10 deaths associated with Gardasil since September 2007, and 140 "serious" reports of adverse reactions, including 27 "life threatening" cases, 10 spontaneous abortions, and 6 cases of the debilitating Guillain-Barre Syndrome since January 2008.

Judicial Watch also found 8,864 Vaccine Adverse Event Reporting System (VAERS) records associated with Gardasil, more than double the 3,461 events that had been reported with the HPV vaccine in Fall 2007. Many experienced outbreaks of genital warts from the HPV vaccine.

The watchdog group says the number of deaths associated with the vaccine is at least 18 and possibly as many as 20.

Eleven deaths occurred less than a week after receiving the vaccine. Seven women died in less than two days. The most common diagnosed cause was blood clotting. One woman died from a clot within 3 hours of the vaccine. One 20-year-old woman, with no medical history reported, died April 4, 2008 just four days after receiving Gardasil.

The serious adverse events include anaphylactic shock, grand mal convulsion, foaming at mouth, coma, paralysis, and death.

Another 23 year-old woman was vaccinated with her first dose of Gardasil on January 31, 2008 and thereupon went into anaphylactic shock. The report says, "patient experienced anaphylactic shock 2 minutes after vaccination characterized by a brief loss of consciousness... respiratory arrest, eyes rolled upwards, blurred vision and greyish skin tone... Anaphylactic shock was considered to be immediately life-threatening."

A 14 year-old girl took six steps after being injected with the vaccine before she collapsed to the floor unconscious and foaming at the mouth. The girl regained consciousness after "a 60 second grand mal seizure" and had "pale clammy skin" and blood pressure of 60/40.

A VAERS report from a physician stated a female patient was inoculated with a dose of Gardasil and, "Subsequently, the patient experienced a coma and is now paralyzed."

Merck & Co. has invested heavily in getting US states to mandate Gardasil to schoolgirls as young as 11 for sexually transmitted HPV in order to beat out rival GlaxoSmithKline's vaccine Cervarix. Merck successfully lobbied the FDA to fast track Gardasil to the market, which critics have charged essentially makes US women part of a massive testing experiment.

JPMorgan Analyst Chris Schott told Forbes.com that since GlaxoSmithKline PLC was delaying submitting more information to the FDA on its cervical cancer treatment Cervarix until the first half of 2009, he projects Merck to dominate the market, while Cervarix will manage only 25% market share by 2012.

"Given all the questions about Gardasil, the best public health policy would be to re-evaluate its safety and to prohibit its distribution to minors," said Judicial Watch President Tom Fitton. "In the least, governments should rethink any efforts to mandate or promote this vaccine for children."

Read the special report by Judicial Watch:



Feature Spotlight

* The Surprising Link Video
* Send Letter to Editor
* Abortion Methods


* Get News by E-mail
* Subscribe Friends
* Donate
* About LifeSiteNews
* Contact Us
* Send News Tips
* RSS News Feed

Get Involved

* Politics
* International
* What Can I Do?

Get Informed

* Educational Information
* News Partners
* Culture Features

Get Help

* Crisis Pregnancy Support

Thursday September 20, 2007

Deaths Associated with HPV Vaccine Start Rolling In, Over 3500 Adverse Affects Reported



By John-Henry Westen

TORONTO, September 20, 2007 (LifeSiteNews.com) - As Canada, in large part due to aggressive behind the scenes lobbying, rolls out the not-comprehensively-tested Merck HPV vaccine for girls as young as nine, a look at developments on the vaccine south of the border should cause Canadians serious concern. In the United States a similar lobby campaign by the same company launched the mass HPV vaccination of girls beginning in June last year.

In just little over a year, the HPV vaccine has been associated with at least five deaths, not to mention thousands of reports of adverse effects, hundreds deemed serious, and many that required hospitalization.

Judicial Watch, a U.S. government watchdog, became concerned while noting large donations to key politicians originating from Merck. A freedom of information request from the group in May of this year discovered that during the period from June 8, 2006 - when the vaccines received approval from the U.S. Food and Drug Administration (FDA) - to May 2007 there were 1,637 reports of adverse reactions to the HPV vaccine reported to the FDA.

Three deaths were related to the vaccine, including one of a 12-year-old. One physician's assistant reported that a female patient "died of a blood clot three hours after getting the Gardasil vaccine." Two other reports, on girls 12 and 19, reported deaths relating to heart problems and/or blood clotting.

As of May 11, 2007, the 1,637 adverse vaccination reactions reported to the FDA via the Vaccine Adverse Event Reporting System (VAERS) included 371 serious reactions. Of the 42 women who received the vaccine while pregnant, 18 experienced side effects ranging from spontaneous abortion to fetal abnormities.

Side effects published by Merck & Co. warn the public about potential pain, fever, nausea, dizziness and itching after receiving the vaccine. Indeed, 77% of the adverse reactions reported are typical side effects to vaccinations. But other more serious side effects reported include paralysis, Bells Palsy, Guillain-Barre Syndrome, and seizures.

Judicial Watch informed LifeSiteNews.com that a subsequent request for information on adverse reactions to the HPV vaccine, covering the period from May 2007 to September 2007, found that an additional 1800 adverse reactions have been reported, including more deaths. Exactly how many more deaths occurred will be released in the coming days, Judicial Watch's Dee Grothe informed LifeSiteNews.com.

The LifeSiteNews.com report on the moneyed lobbying efforts of Merck in the U.S. was reported in February. (see http://www.lifesitenews.com/ldn/2007/feb/07020204.html )

However the Canadian lobby effort by Merck's Canadian affiliate Merck Frosst Canada has been underway using powerful lobbyists with close connections to the politicians who have signed off on massive government funded vaccination programs.

The Toronto Star recently reported that Merck Frosst Canada Ltd hired public relations giant Hill & Knowlton to push the immunization strategies using some well-connected lobbyists: Ken Boessenkool, a former senior policy adviser to Prime Minister Stephen Harper; Bob Lopinski, formerly with Premier Dalton McGuinty's office; and Jason Grier, former chief of staff to Health Minister George Smitherman.

Harper's Conservative Government approved Merck's HPV vaccine Gardasil in July and later announced a $300 million program to give the vaccine to girls from ages 9-13. That of course is only the beginning of what Merck likely hopes will be a much larger vaccination of all potentially sexually active women in Canada who are not already HPV infected. In August, McGuinty's Ontario Liberals, on the advice of his Health Minister George Smitherman, announced that all Grade 8 girls will have free access to Gardasil.

One of the major complaints by physicians is that the HPV vaccination program has been implemented before adequate testing has been completed. Long-term effects of the vaccine remain unknown. Many are asking why the seemingly reckless rush?

At least one answer to that question comes from the fact that Merck currently is the sole provider of an HPV vaccine with its Gardasil product. A competing HPV vaccine, Glaxo Smith Kline's Cervarix, is set to hit the market in January 2008. As more children are vaccinated with Gardasil, fewer will be able to later receive the necessary repeat boosters of a competing, incompatible vaccine. Merck is in a race to capture as much of the market as it can, consuming many millions of taxpayer dollars.

U.S. sales of Gardasil are expected to reach $1 billion in the first year of its availability.

Read Previous LifeSiteNews.com coverage:

The reports from the FDA Vaccine Adverse Event Reporting System detailing the three previous deaths are available here:

The reports detailing all 1637 adverse effects are here:

w w w . a l l i a n c e f o r l i f e . o r g

Is it Safe for
My Daughter?

Testing involving Gardasil with other childhood
vaccines has only been conducted with the Hep-
atitis B vaccine. The National Vaccine Informa-
tion Center called on the FDA and CDC to
issue warnings that Gardasil should not be com-
bined with other vaccines, and that girls be
monitored for fainting, seizures, tingling, numb-
ness and loss of sensation in the fingers and
limbs for 24 hours after vaccination.
The long-term effects of the vaccine on young
girls are completely unknown. Merck states in
its product insert that Gardasil has not been
tested to see if it causes cancer
or if a
young woman’s reproductive health will be
Additionally, Merck acknowl-
edges that the vaccine has not been tested
for genotoxicity (testing to see if the vaccine
is toxic to human DNA).
“A careful review of the literature, includ-
ing that submitted by the manufacturer
with its application for approval of Gar-
dasil reveals a sufficient number of unan-
swered questions to lead us to conclude
that a universal immunization program
aimed at girls and women in Canada is, at
this time, premature and could possibly
have unintended consequences for indi-
viduals and for society as a whole.”
Dr. Abby Lippma,
Canadian epidemiologist, McGill University
Gardasil is being hailed as one of the major
health advances of the early 21st century and
yet many parents have refused to accept this
vaccine as a just another regimen in their
child’s immunization schedule. Given all the
questions concerning Gardasil’s safety, and the
fact that the vaccine is still in the testing stages,
we recommend that concerned parents inform
themselves of the facts and request that the
government and public health officials
suspend their distribution to minor girls until
its safety can be adequately proven.



Most parents are unaware that their child, regard-
less of age,could be considered capable of mak-
ing her own healthcare decisions in Ontario.
This means that your daughter can choose to ac-
cept or refuse immunization, even if you have
indicated otherwise in a consent form.
Public health nurses are required to ask every
student if they understand, have any questions,
and consent to be immunized. If the parent
wishes the student to be immunized and the stu-
dent refuses, the immunization will not be given.
Likewise, a student who is judged capable of giv-
inginformed consent may be immunized even if
the parents have not consented.

What Parents Need To Know

This vaccine should not be mandated for 11-
year-old girls.... It's not been tested in little
girls for efficacy. At 11, these girls don't get
cervical cancer — they won't know for 25
years if they will get cervical cancer. Giving it
to 11-year-olds is a great big public health ex-

Dr. Diane Harper,
Lead researcher, HPV vaccine development


Thursday August 21, 2008

Articles in Prominent Medical Journal Doubt Worth and Benefit of HPV Vaccines



By Tim Waggoner

WASHINGTON, August 21, 2008 (LifeSiteNews.com) – The New England Journal of Medicine posted two articles this week that asked why two human papillomavirus vaccines have been so widely distributed given their unproven effectiveness and high costs.

Gardasil by Merck Sharp & Dohme, which has already received tremendous criticism for the severe and fatal side-effects experienced by users, and Cervarix by GlaxoSmithKline were the two drugs called to question.

As reported by the New York Times, Dr. Charlotte J. Haug, editor of The Journal of the Norwegian Medical Association, whose editorial appeared in Thursday's issue of The New England Journal, said, "Despite great expectations and promising results of clinical trials, we still lack sufficient evidence of an effective vaccine against cervical cancer. With so many essential questions still unanswered, there is good reason to be cautious."

Both vaccines were tested for relatively short periods of time, revealed Dr. Haug, and researchers are yet to prove whether or not the vaccines offer lasting immunity and if a user's natural immunity to other strains not eliminated by the vaccines will be compromised. Dr. Haug said it is not certain if the protection offered by the vaccines will even lead to reduced rates of cervical cancer.

Jane J. Kim and Dr. Sue Goldie of Harvard, who likewise had a study published in this week's issue of the medical journal, also brought up the fact that the vaccines have not been proven to offer life-long protection. They said that until this is certain, the cost of the vaccines cannot be justified.

Furthermore, the costs of the vaccines cannot be offset by eliminating Pap smear screening because the test is still needed to identify HPV strands that the vaccines do not protect against.

These studies criticizing the effectiveness and cost of the HPV vaccines could not come at worse time for Merck – the drug giant is under fire because of a reported 9,749 cases of severe side-effects and 21 deaths associated with Gardasil.

See related LifeSiteNews.com coverage:

HPV Vaccine Causes 21 Deaths and Counting - CDC Study Launched

1 comment:

INV. said...

Vioxx have caused blood clots and stroke,Fosamax caused "jaw rotting"
abnormalities,Gardasil can kill you
or paralyze you. Boycott all Merck
products.Do everything in your power to stay healthy.